Our Location

07 3221 9066

X

Different flu vaccines? Southern vs Northern hemisphere

October 15th, 2025

The vaccines for southern hemisphere 2025  and northern hemisphere 2025/6  cover basically the same influenza strains.

2025 Southern 
The egg-based trivalent influenza vaccines contain the following three viral strains:

• an A/Victoria/4897/2022 (H1N1)pdm09-like virus
• an A/Croatia/10136RV/2023 (H3N2)-like virus
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.

Cell-based trivalent influenza vaccines contain the following three viral strains:

• an A/Wisconsin/67/2022 (H1N1)pdm09-like virus
• an A/District of Columbia/27/2023 (H3N2)-like virus
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.

Quadrivalent egg- or cell culture-based or recombinant vaccines contain the following B/Yamagata lineage component:

• a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

Source

https://www.tga.gov.au/resources/publication/publications/2025-seasonal-influenza-vaccines

2026 Northern
The WHO recommends that trivalent vaccines for use in the 2025-2026 northern hemisphere influenza season contain the following:
Egg-based vaccines
• an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
• an A/Croatia/10136RV/2023 (H3N2)-like virus; and
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
Cell culture-, recombinant protein- or nucleic acid-based vaccines
• an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
• an A/District of Columbia/27/2023 (H3N2)-like virus; and
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
The recommendation for the B/Yamagata lineage component of quadrivalent influenza vaccines remains unchanged from previous recommendations:
• a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
source
https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2025-2026-nh-influenza-season

I recommend the CELL based influenza vaccine rather EGG based, as the evidence supports that cell based vaccines are slightly more effective than egg based ones.

Optimal protection offered by the influenza vaccine lasts for 3–4 months following vaccination; after this, the level of protection begins to decrease.

There is however limited evidence that supports the need for a second dose within the one season for most people.
Travellers whose immune system is weakened for some reason should discuss the need for a second dose with their doctor.

Leave a Reply

Creative Commons License
This work by Dr Deb The Travel Doctor Pty Ltd (ABN 75 624 360 247) is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Permissions beyond the scope of this license may be available at our terms & conditions.

© 2025 Dr. Deb’s | All Rights Reserved | Privacy Policy | Website Terms and Conditions | Governing policy | Sitemap